Tellurium nanoparticle-loaded dissoluble microneedle and preparation method thereof
By designing soluble microneedles loaded with tellurium nanoparticles, using the method of combining water-soluble polymers and tellurium nanoparticles, the problems of uneven release and insufficient mechanical properties of existing microneedles during drug delivery are solved. Efficient and stable drug delivery and improved drug utilization.
Patent Information
- Application Number
- CN202411282164.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-05-20
- Filing Date
- 2024-09-12
- Publication Date
- 2024-12-06
AI Technical Summary
During the drug delivery process, existing soluble microneedles have problems such as uneven drug release, poor stability, low mechanical properties, easy infection and low penetration efficiency. In particular, the needle body is difficult to completely insert into the skin, resulting in low drug delivery efficiency. and insufficient drug loading.
Design a soluble microneedle loaded with tellurium nanoparticles. The needle body and needle tip are filled with water-soluble polymer and tellurium nanoparticles. It is prepared by a microneedle array mold with a vacuum method to fill the needle tip and needle body solution. Improve the mechanical properties and drug-loading efficiency of microneedles, and obtain mechanical strength and biocompatibility through specific preparation methods.
It achieves efficient and stable delivery of drugs, improves the bioavailability of drugs, reduces side effects, enhances the penetration and stability of microneedles, and improves the utilization rate of drugs and puncture rate.
Smart Images

Figure CN119074633A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of biomedicine technology, and specifically relates to a soluble microneedle loaded with tellurium nanoparticles and a preparation method thereof. Background Art
[0002] With the rapid development of nanotechnology, the application of nanomaterials in the field of biomedicine has gradually shown its unique advantages. Among them, tellurium nanoparticles have broad application prospects in the field of biomedicine due to their unique physical and chemical properties, such as good biocompatibility, high specific surface area and excellent photothermal performance. In particular, tellurium nanoparticles have shown great potential in the fields of vaccine delivery, cancer treatment and bioimaging.
[0003] On the other hand, as a new drug delivery method, soluble microneedle technology penetrates the stratum corneum of the skin through a microneedle array to form a microchannel, delivers drugs to the dermis with minimal invasion and precise control, and directly delivers drugs to the deep tissue of the skin without stimulating the nerve endings related to the skin. It not only avoids the pain and cross-infection caused by traditional injections, but also effectively avoids the first-pass effect and side effects of oral drugs, as well as the narrow reaction window and poor reaction rate of oral drugs. It has multiple advantages. As a new drug delivery method, soluble microneedles break the limitations of traditional transdermal preparations. Local treatment has high targeting, which can reduce the frequency and dosage of administration to a certain extent and save resources. At the same time, soluble microneedles have the advantages of easy use, accurate dosage, and good patient adaptability, so they have received widespread attention in the field of biomedicine.
[0004] However, the soluble microneedles currently on the market have certain limitations, and there are problems such as uneven drug release and poor stability during drug delivery. For example, it is difficult for microneedles to be fully inserted into the skin, which limits the transdermal release of drugs; the microneedles have low mechanical properties and insufficient strength, which may cause the needle body to break and cause infection during the insertion of the skin; lipophilic drugs have poor solubility in microneedles, so the drug loading is usually low; microneedles are mostly made of solid materials, which have poor solubility; therefore, optimizing the soluble microneedle structure for drug delivery systems, developing a soluble microneedle loaded with tellurium nanoparticles with a thinner bottom, better mechanical strength and photothermal performance, and achieving efficient and stable drug delivery have important theoretical significance and practical application value. Summary of the invention
[0005] In view of the above problems, the first object of the present invention is to provide a soluble microneedle loaded with tellurium nanoparticles with a thinner bottom and better mechanical strength. The soluble microneedle can also improve the bioavailability of drugs and reduce the side effects of drugs, effectively solving the problems existing in the drug delivery process of existing microneedles, such as easy to cause infection, low penetration efficiency, and low drug delivery efficiency.
[0006] The second object of the present invention is to provide a method for preparing soluble microneedles loaded with tellurium nanoparticles.
[0007] To this end, the first technical solution provided by the present invention is as follows:
[0008] A soluble microneedle loaded with tellurium nanoparticles comprises a needle body and a needle tip at the upper end of the needle body, wherein the needle tip is filled with water-soluble high molecular polymer and water-soluble medicine, and the needle body is filled with water-soluble high molecular polymer and tellurium nanoparticles.
[0009] The water-soluble drugs can be selected according to the specific disease treatment needs, such as gemcitabine hydrochloride, carboplatin, cytarabine hydrochloride, nitrogen mustard hydrochloride, mitoxantrone hydrochloride, including but not limited to the above-mentioned drugs.
[0010] Furthermore, in the above-mentioned soluble microneedles loaded with tellurium nanoparticles, the high molecular polymer is one or more of hyaluronic acid, chondroitin sulfate, polyvinyl alcohol, sodium alginate, polyoxazoline, carboxymethyl chitosan, carboxymethyl cellulose, γ-polyglutamic acid and gelatin.
[0011] Furthermore, in the above-mentioned soluble microneedles loaded with tellurium nanoparticles, the water-soluble high molecular polymer is a composition of hyaluronic acid, chondroitin sulfate and carboxymethyl chitosan.
[0012] Furthermore, the above-mentioned soluble microneedles loaded with tellurium nanoparticles, the tellurium nanoparticles are prepared by the following method:
[0013] Weigh bovine serum albumin and add it to a conical flask filled with deionized water. Use a magnetic stirrer to stir continuously, then slowly drop a deionized Na2TeO3 solution into it, continue stirring and then slowly drop a deionized NaBH4 solution into it, and continue stirring to react for 30 minutes; then let the conical flask stand at room temperature for 12 hours to obtain a dark purple tellurium nano solution; dialyze the solution using a 100KD dialysis bag for 48 hours, changing the water every 4 hours, and after the dialysis is completed, pass the solution through a 0.22μm needle filter membrane to remove larger particles, freeze it at -80℃ for 24 hours, and then freeze-dry it in a freeze dryer to obtain a fluffy black solid, which is the final purified tellurium nanoparticles, which are stored at -20℃ in the dark.
[0014] Furthermore, the above-mentioned method for preparing tellurium nanoparticles is characterized in that the bovine serum albumin content is 2-6 mg / mL, the concentration of Na2TeO3 deionized water solution is 40-80 mg / mL, and the concentration of NaBH4 deionized water solution is 50-90 mg / mL.
[0015] Furthermore, the above-mentioned soluble microneedles loaded with tellurium nanoparticles have a quadrangular prism-shaped needle body and a quadrangular pyramid-shaped needle tip; or a cylindrical needle body and a conical needle tip; the needle body height is 300 to 1500 μm, the microneedle bottom diameter is 200 to 600 μm; and the distance between two adjacent needle tip tips is 500 to 1500 μm.
[0016] The second technical solution provided by the present invention is a method for preparing the above-mentioned soluble microneedles loaded with tellurium nanoparticles, which comprises the following steps in sequence:
[0017] 1) pouring polydimethylsiloxane on the master mold structure of the microneedle array, and demoulding after curing and molding to obtain a negative mold microneedle array mold opposite to the master mold structure of the microneedle array;
[0018] 2) Adding a water-soluble polymer to deionized water and stirring for 2 to 24 hours to obtain a needle tip solution;
[0019] 3) Mixing the water-soluble polymer and tellurium nanoparticles, adding deionized water and stirring for 2 to 24 hours, and mixing evenly to obtain a needle body solution;
[0020] 4) adding the needle tip solution prepared in 2) to the negative mold microneedle array mold of 1) and filling the groove of the substrate with the solution, using a vacuum dryer to evacuate the needle tip solution to the needle tip of the microneedle mold, removing the residual solution on the surface, and drying in an oven or naturally;
[0021] 5) adding the needle tip solution prepared in 2) to the negative mold microneedle array mold of 4) and filling the groove of the substrate with the solution, using a vacuum dryer to evacuate the air so that the needle tip solution enters the needle tip of the microneedle mold, removing the residual solution on the surface, and drying in an oven or naturally to concentrate the needle tip;
[0022] 6) Add the needle body solution prepared in 3) to the negative mold microneedle array mold of 1), and fill the grooves of the substrate with the solution. Use a vacuum dryer to evacuate the air so that the needle body solution fills the needle body part and the substrate of the microneedle mold. Dry at room temperature and demold to obtain soluble microneedles loaded with tellurium nanoparticles.
[0023] Furthermore, in the above-mentioned method for preparing soluble microneedles loaded with tellurium nanoparticles, the mass percentage of water-soluble high molecular polymer in the needle tip solution described in step 2) and the needle body solution described in step 3) is 20% to 35%; the concentration of the tellurium nanoparticle solution in step 3) is 50 to 800 μg / mL.
[0024] Furthermore, in the method for preparing the soluble microneedles loaded with tellurium nanoparticles, the amount of the needle tip solution used in 4) is 50 to 250 μL, and the drying condition is drying at 20 to 50° C. for 2 to 5 hours.
[0025] Furthermore, in the above method for preparing soluble microneedles loaded with tellurium nanoparticles, the amount of needle body solution used in 6) is 50 to 250 μL, and the drying time is 12 h to 24 h.
[0026] Furthermore, in the above method for preparing soluble microneedles loaded with tellurium nanoparticles, the number of needles of the single-piece square microneedle array prepared by the negative mold microneedle array mold in step 1) is 10×10 or 15×15.
[0027] Compared with the prior art, the present invention has the following beneficial effects:
[0028] 1. The technical solution provided by the present invention uses a vacuum method to fill the needle tip and needle body solution in the negative mold microneedle array mold, and concentrates the drug at the tip of the microneedle to improve the mechanical properties and drug loading efficiency of the microneedle. The microneedle patch prepared by combining tellurium nanoparticles with water-soluble high molecular polymers has good biocompatibility and a soft backing without affecting its mechanical properties. The mechanical strength is 0.16 to 1N, which can penetrate the skin. It can effectively penetrate the skin to deliver drugs while fitting the skin. In addition, the preparation process is simple and fast, which is conducive to mass production.
[0029] 2. The technical solution provided by the present invention is used to prepare microneedles with a thin bottom, which can better fit the human skin, thereby solving the problem of low puncture rate in the human body caused by the thick bottom of the microneedle to a certain extent, and can effectively improve the stability, puncture rate and drug utilization rate of the microneedle. BRIEF DESCRIPTION OF THE DRAWINGS
[0030] Figure 1 This is a schematic longitudinal section of a mold for preparing soluble microneedles loaded with tellurium nanoparticles according to Example 1 of the present invention;
[0031] Figure 2 This is a TEM result of the tellurium nanoparticles used in Example 1 of the present invention;
[0032] Figure 3 This is a digital photo of the soluble microneedles loaded with tellurium nanoparticles according to Example 1 of the present invention;
[0033] Figure 4 This is a stereomicroscope image of the soluble microneedles loaded with tellurium nanoparticles according to Example 1 of the present invention;
[0034] Figure 5 This is a diagram showing the mechanical properties of the soluble microneedles loaded with tellurium nanoparticles according to Example 1 of the present invention;
[0035] Figure 6 These are digital photos of the soluble microneedles of Example 1 and Comparative Example 1 of the present invention;
[0036] Figure 7 This is a diagram of the mechanical properties of the soluble microneedle of Comparative Example 1;
[0037] Figure 8 This is a diagram showing the mechanical properties of the soluble microneedles of Comparative Example 2 that do not contain tellurium nanoparticles. DETAILED DESCRIPTION
[0038] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. The following implementation methods are only used to illustrate the present invention, not to limit the present invention. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0039] It should be noted that there are no special restrictions on the present application, and all operations are carried out in accordance with conventional technical means in the field.
[0040] Example 1
[0041] This embodiment provides a method for preparing a soluble microneedle loaded with tellurium nanoparticles, comprising the following steps:
[0042] 1) pouring polydimethylsiloxane on the master mold structure of the microneedle array, demolding after curing and molding, and obtaining a negative mold microneedle array mold opposite to the master mold structure of the microneedle array, and the parameters of the microneedle array prepared by the mold are: each microneedle patch contains 225 needles, which is a 15×15 array, and the shape of the microneedle includes a cylindrical needle body, a conical needle tip is provided on the upper part of the needle body, the cylindrical needle body is 500 μm long, the conical needle tip is 400 μm long, and a 100 μm thick truncated cone base is used to connect the microneedle body and the substrate, the overall needle height is 1000 μm, the needle body diameter is 250 μm, the distance between two adjacent needle tips is 800 μm, and the substrate thickness is 200 μm;
[0043] 2) 600 mg of chondroitin sulfate, 150 mg of carboxymethyl chitosan and 60 mg of the simulated drug rhodamine were added to the container and mixed, and then 3 mL of deionized water was added and stirred to obtain a needle tip solution;
[0044] 3) 600 mg of chondroitin sulfate, 150 mg of carboxymethyl chitosan and 200 μg of tellurium nanoparticles were added to a container and mixed, and then 3 mL of deionized water was added and stirred to obtain a needle body solution;
[0045] 4) 250 μL of the needle tip solution prepared in 2) was added to the negative mold microneedle array mold in 1), and vacuumed for 5 min using a vacuum dryer with a vacuum degree of -0.05 MPa to allow the solution to enter the needle tip of the microneedle mold, and the residual solution on the surface was removed, and the mixture was dried naturally for 4 h;
[0046] 5) 250 μL of the needle tip solution prepared in 2) was added to the negative mold microneedle array mold in 4), and vacuumed for 5 min using a vacuum dryer with a vacuum degree of -0.05 MPa to allow the solution to enter the needle tip of the microneedle mold, remove the residual solution on the surface, and dry naturally for 4 h to achieve the purpose of concentrating the needle tip;
[0047] 6) 250 μL of the needle body solution prepared in 3) was added to the negative mold microneedle array mold in 5), and vacuumed for 5 min using a vacuum dryer with a vacuum degree of -0.05 MPa to allow the solution to fill the needle body and the backing of the microneedle mold, and dried at room temperature for 12 h. After demolding, soluble microneedles loaded with tellurium nanoparticles were obtained;
[0048] Example 2
[0049] This embodiment provides a method for preparing a soluble microneedle loaded with tellurium nanoparticles, comprising the following steps:
[0050] 1) pouring polydimethylsiloxane on the master mold structure of the microneedle array, demolding after curing and molding, and obtaining a negative mold microneedle array mold opposite to the master mold structure of the microneedle array, and the parameters of the microneedle array prepared by the mold are: each microneedle patch contains 225 needles, which is a 15×15 array, and the microneedle shape is cylindrical + conical, the cylindrical needle body length is 500 μm, the conical needle tip length is 400 μm, and the truncated cone base with a thickness of 100 μm is used to connect the microneedle body and the substrate, the overall needle height is 1000 μm, the needle body diameter is 250 μm, the distance between two adjacent needle tips is 800 μm, and the substrate thickness is 200 μm;
[0051] 2) 300 mg of chondroitin sulfate and 20 mg of the simulated drug rhodamine were added to the container and mixed, and then 1 mL of deionized water was added and stirred to obtain a needle tip solution;
[0052] 3) Add 300 mg of chondroitin sulfate and 100 μg of tellurium nanoparticles into a container and mix, then add 1 mL of deionized water and stir, mix evenly to obtain a needle body solution;
[0053] 4) 250 μL of the needle tip solution prepared in 2) was added to the negative mold microneedle array mold in 1), and vacuumed for 5 min using a vacuum dryer with a vacuum degree of -0.05 MPa to allow the solution to enter the needle tip of the microneedle mold, and the residual solution on the surface was removed, and the mixture was dried naturally for 4 h;
[0054] 5) 250 μL of the needle tip solution prepared in 2) was added to the negative mold microneedle array mold in 4), and vacuumed for 5 min using a vacuum dryer with a vacuum degree of -0.05 MPa to allow the solution to enter the needle tip of the microneedle mold, and the residual solution on the surface was removed, and the solution was naturally dried for 4 h to concentrate the needle tip;
[0055] 6) Take 250 μL of the needle body solution prepared in 3) and add it to the negative mold microneedle array mold in 5), and use a vacuum dryer with a vacuum degree of -0.05 MPa to evacuate for 5 minutes so that the solution fills the needle body part and the base of the microneedle mold. Dry at room temperature for 12 hours, and after demolding, obtain soluble microneedles loaded with tellurium nanoparticles.
[0056] Example 3
[0057] This embodiment provides a method for preparing a soluble microneedle loaded with tellurium nanoparticles, comprising the following steps:
[0058] 1) pouring polydimethylsiloxane on the master mold structure of the microneedle array, demolding after curing and molding, and obtaining a negative mold microneedle array mold opposite to the master mold structure of the microneedle array, and the parameters of the microneedle array prepared by the mold are: each microneedle patch contains 100 needles, which is a 10×10 array, the microneedle shape is a quadrangular pyramid, the overall needle height is 620 μm, the bottom hypotenuse length is 200 μm, the distance between two adjacent needle tips is 500 μm, and the base thickness is 200 μm;
[0059] 2) 200 mg of chondroitin sulfate, 50 mg of carboxymethyl chitosan and 20 mg of the simulated drug rhodamine were added to the container and mixed, and then 1 mL of deionized water was added and stirred to obtain a needle tip solution;
[0060] 3) Add 200 mg of chondroitin sulfate, 50 mg of carboxymethyl chitosan and 200 μg of tellurium nanoparticles into a container and mix, then add 1 mL of deionized water and stir, mix evenly to obtain a needle body solution;
[0061] 4) 150 μL of the needle tip solution prepared in 2) was added to the negative mold microneedle array mold in 1), and vacuumed for 5 min using a vacuum dryer with a vacuum degree of -0.05 MPa to allow the solution to enter the needle tip of the microneedle mold, and the residual solution on the surface was removed, and the mixture was dried naturally for 4 h;
[0062] 5) 250 μL of the needle tip solution prepared in 2) was added to the negative mold microneedle array mold in 4), and vacuumed for 5 min using a vacuum dryer with a vacuum degree of -0.05 MPa to allow the solution to enter the needle tip of the microneedle mold, and the residual solution on the surface was removed, and the solution was naturally dried for 4 h to concentrate the needle tip;
[0063] 6) Take 150 μL of the needle body solution prepared in 3) and add it to the negative mold microneedle array mold in 5), and evacuate with a vacuum pump for 5 minutes to allow the solution to fill the needle body part and the base of the microneedle mold. Dry at room temperature for 12 hours, and after demolding, obtain soluble microneedles loaded with tellurium nanoparticles.
[0064] Example 4
[0065] This embodiment provides a method for preparing a soluble microneedle loaded with tellurium nanoparticles, comprising the following steps:
[0066] 1) pouring polydimethylsiloxane on the master mold structure of the microneedle array, demolding after curing and molding, and obtaining a negative mold microneedle array mold opposite to the master mold structure of the microneedle array, and the parameters of the microneedle array prepared by the mold are: each microneedle patch contains 100 needles, which is a 10×10 array, the microneedle shape is a quadrangular pyramid, the overall needle height is 600 μm, the bottom hypotenuse length is 200 μm, the distance between two adjacent needle tips is 500 μm, and the base thickness is 200 μm;
[0067] 2) 240 mg of chondroitin sulfate, 60 mg of polyoxazoline and 20 mg of the simulated drug rhodamine were added to the container and mixed, and then 1 mL of deionized water was added and stirred to obtain a needle tip solution;
[0068] 3) Add 240 mg of chondroitin sulfate, 60 mg of polyoxazoline and 200 μg of tellurium nanoparticles into a container and mix, then add 1 mL of deionized water and stir, mix evenly to obtain a needle body solution;
[0069] 4) 150 μL of the needle tip solution prepared in 2) was added to the negative mold microneedle array mold in 1), and vacuumed for 5 min using a vacuum dryer with a vacuum degree of -0.05 MPa to allow the solution to enter the needle tip of the microneedle mold, and the residual solution on the surface was removed, and the mixture was dried naturally for 4 h;
[0070] 5) 250 μL of the needle tip solution prepared in 2) was added to the negative mold microneedle array mold in 4), and vacuumed for 5 min using a vacuum dryer with a vacuum degree of -0.05 MPa to allow the solution to enter the needle tip of the microneedle mold, and the residual solution on the surface was removed, and the solution was naturally dried for 4 h to concentrate the needle tip;
[0071] 6) Take 150 μL of the needle body solution prepared in 3) and add it to the negative mold microneedle array mold in 5), and use a vacuum dryer with a vacuum degree of -0.05 MPa to evacuate for 2 minutes so that the solution fills the needle body part and the base of the microneedle mold. Dry at room temperature for 12 hours, and after demolding, obtain soluble microneedles loaded with tellurium nanoparticles.
[0072] The tellurium nanoparticles described in Examples 1-4 are prepared by the following method:
[0073] Weigh 0.2 g of bovine serum albumin and add it to a conical flask containing 40 mL of deionized water. Use a magnetic stirrer to stir continuously, then slowly drop a 65 mg / mL Na2TeO3 deionized water solution, continue stirring and then slowly drop a 75 mg / mL NaBH4 deionized water solution, and continue stirring to react for 30 minutes; then let the conical flask stand at room temperature for 12 hours to obtain a dark purple tellurium nano solution; dialyze the solution using a 100KD dialysis bag for 48 hours, changing the water every 4 hours, and after the dialysis is completed, pass the solution through a 0.22 μm needle filter membrane to remove larger particles, freeze it at -80°C for 24 hours, and then freeze-dry it in a freeze dryer to obtain a fluffy black solid, which is the final purified tellurium nanoparticles, which are stored at -20°C in the dark.
[0074] Comparative Example 1
[0075] This comparative example provides a method for preparing a soluble microneedle, comprising the following steps:
[0076] 1) pouring polydimethylsiloxane on the master mold structure of the microneedle array, demolding after curing and molding, and obtaining a negative mold microneedle array mold opposite to the master mold structure of the microneedle array, and the parameters of the microneedle array prepared by the mold are: each microneedle patch contains 100 needles, which is a 10×10 array, the microneedle shape is a quadrangular pyramid, the overall needle height is 620 μm, the bottom side length is 100 μm, the distance between two adjacent needle tips is 300 μm, and the base thickness is 500 μm;
[0077] 2) Add 200 mg of chondroitin sulfate and 50 mg of carboxymethyl chitosan into a container and mix, then add 1 mL of deionized water and stir, mix evenly to obtain a microneedle preparation solution;
[0078] 3) 150 μL of the solution prepared in 2) was added to the negative mold microneedle array mold of 1), and vacuum was drawn for 5 min using a vacuum dryer with a vacuum degree of -0.05 MPa to allow the solution to fill the needle body and the base of the microneedle mold, and then naturally dried at room temperature for 12 h. After demolding, soluble microneedles loaded with tellurium nanoparticles were obtained.
[0079] Comparative Example 2
[0080] This comparative example provides a method for preparing a soluble microneedle without tellurium nanoparticles, comprising the following steps:
[0081] 1) pouring polydimethylsiloxane on the master mold structure of the microneedle array, demolding after curing and molding, and obtaining a negative mold microneedle array mold opposite to the master mold structure of the microneedle array, and the parameters of the microneedle array prepared by the mold are: each microneedle patch contains 225 needles, which is a 15×15 array, and the microneedle shape is cylindrical + conical, the cylindrical needle body length is 500 μm, the conical needle tip length is 400 μm, and the truncated cone base with a thickness of 100 μm is used to connect the microneedle body and the substrate, the overall needle height is 1000 μm, the needle body diameter is 250 μm, the distance between two adjacent needle tips is 800 μm, and the substrate thickness is 200 μm;
[0082] 2) 300 mg of chondroitin sulfate, 50 mg of carboxymethyl chitosan and 20 mg of the simulated drug rhodamine were added to the container and mixed, and then 1 mL of deionized water was added and stirred to obtain a needle tip solution;
[0083] 3) Add 300 mg of chondroitin sulfate and 50 mg of carboxymethyl chitosan into a container and mix, then add 1 mL of deionized water and stir, mix evenly to obtain a needle body solution;
[0084] 4) 250 μL of the needle tip solution prepared in 2) was added to the negative mold microneedle array mold in 1), and vacuumed for 5 min using a vacuum dryer with a vacuum degree of -0.05 MPa to allow the solution to enter the needle tip of the microneedle mold, and the residual solution on the surface was removed, and the mixture was dried naturally for 4 h;
[0085] 5) 250 μL of the needle tip solution prepared in 2) was added to the negative mold microneedle array mold in 4), and vacuumed for 5 min using a vacuum dryer with a vacuum degree of -0.05 MPa to allow the solution to enter the needle tip of the microneedle mold, and the residual solution on the surface was removed, and the solution was naturally dried for 4 h to concentrate the needle tip;
[0086] 6) Take 250 μL of the needle body solution prepared in 3) and add it to the negative mold microneedle array mold in 5), and use a vacuum dryer with a vacuum degree of -0.05 MPa to evacuate for 5 minutes so that the solution fills the needle body part and the base of the microneedle mold. Dry at room temperature for 12 hours, and after demolding, obtain soluble microneedles loaded with tellurium nanoparticles.
[0087] Test results:
[0088] The TEM image of the tellurium nanoparticles used in Example 1 is as follows: Figure 2 As shown, the tellurium nanoparticles shown in the figure are rod-shaped structures.
[0089] The softness of the soluble microneedles loaded with tellurium nanoparticles prepared in Example 1 was tested. The test results are as follows: Figure 3 As shown, the microneedle patch has a soft backing that allows it to better fit the skin.
[0090] The soluble microneedles loaded with tellurium nanoparticles prepared in Example 1 were tested using a stereo microscope. The test results are as follows: Figure 4 As shown, the microneedle is a double-layer microneedle consisting of a conical drug-carrying layer and a cylindrical tellurium nanoparticle layer, and the microneedles are arranged neatly and the needle body is intact without defects.
[0091] The mechanical properties of the soluble microneedles loaded with tellurium nanoparticles prepared in Example 1 were tested using a universal testing machine. The test results are as follows: Figure 5 As shown, the maximum withstanding force is 75.38N, and the maximum withstanding force of each needle is 0.335N.
[0092] The soluble microneedles loaded with tellurium nanoparticles prepared in Example 1 were compared with the soluble microneedles prepared in Comparative Example 1. Figure 6 As shown, the dissolvable microneedles prepared in Example 1 have a thinner backing and a wider drug application area.
[0093] The soluble microneedles prepared in Comparative Example 1 were tested for mechanical properties using a universal testing machine. The test results are as follows: Figure 7 As shown, the maximum withstanding force is 19.65N and the maximum withstanding force of each needle is 0.197N.
[0094] The soluble microneedles without tellurium nanoparticles prepared in Comparative Example 2 were tested for mechanical properties using a universal testing machine. The test results are as follows: Figure 8 As shown, the maximum tolerable force is 64.18N and the maximum tolerable force per needle is 0.285N.
[0095] It can be seen from the above experimental data that the maximum tolerable capacity of the soluble microneedles loaded with tellurium nanoparticles provided in the embodiment of the present application and the maximum tolerable capacity of each needle are significantly greater than those of the microneedles provided in the comparative example; therefore, the skin can be penetrated better and can effectively penetrate the skin to deliver drugs while adhering to the skin.
[0096] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A soluble microneedle loaded with tellurium nanoparticles, comprising a needle body and a needle tip at the upper end of the needle body, characterized in that: The needle tip is filled with water-soluble high molecular polymer and water-soluble medicine, and the needle body is filled with water-soluble high molecular polymer and tellurium nanoparticles.
2. The soluble microneedle loaded with tellurium nanoparticles according to claim 1, characterized in that: The high molecular polymer is one or more of hyaluronic acid, chondroitin sulfate, polyvinyl alcohol, sodium alginate, polyoxazoline, carboxymethyl chitosan, carboxymethyl cellulose, gamma-polyglutamic acid and gelatin.
3. The soluble microneedle loaded with tellurium nanoparticles according to claim 2, characterized in that: The water-soluble high molecular polymer is a composition of hyaluronic acid, chondroitin sulfate and carboxymethyl chitosan.
4. The soluble microneedle loaded with tellurium nanoparticles according to claim 1, characterized in that: The water-soluble drugs are necessary water-soluble drugs required for treatment.
5. The soluble microneedle loaded with tellurium nanoparticles according to claim 1, characterized in that: The tellurium nanoparticles are prepared by the following method: Weigh bovine serum albumin and add it to a conical flask filled with deionized water. Use a magnetic stirrer to stir continuously, then slowly drop a deionized Na2TeO3 solution into it, continue stirring and then slowly drop a deionized NaBH4 solution into it, and continue stirring to react for 30 minutes; then let the conical flask stand at room temperature for 12 hours to obtain a dark purple tellurium nano solution; dialyze the solution using a 100KD dialysis bag for 48 hours, changing the water every 4 hours, and after the dialysis is completed, pass the solution through a 0.22μm needle filter membrane to remove larger particles, freeze it at -80℃ for 24 hours, and then freeze-dry it in a freeze dryer to obtain a fluffy black solid, which is the final purified tellurium nanoparticles, which are stored at -20℃ in the dark.
6. The method for preparing tellurium nanoparticles according to claim 5, characterized in that: The content of bovine serum albumin is 2-6 mg / mL, the concentration of Na2TeO3 deionized water solution is 40-80 mg / mL, and the concentration of NaBH4 deionized water solution is 50-90 mg / mL.
7. The soluble microneedle loaded with tellurium nanoparticles according to claim 1, characterized in that: The soluble microneedle body is a quadrangular prism, and the needle tip is a quadrangular pyramid; or the needle body is a cylindrical shape, and the needle tip is a conical shape; the needle body height is 300-1500 μm, and the diameter of the microneedle bottom is 200-600 μm.
8. The method for preparing soluble microneedles loaded with tellurium nanoparticles according to claim 1, characterized in that: The steps are as follows: 1) pouring polydimethylsiloxane on the master mold structure of the microneedle array, and demoulding after curing and molding to obtain a negative mold microneedle array mold opposite to the master mold structure of the microneedle array; 2) Adding a water-soluble polymer to deionized water and stirring for 2 to 24 hours to obtain a needle tip solution; 3) Mixing a water-soluble polymer and tellurium nanoparticles, adding deionized water and stirring for 2 to 24 hours, and mixing evenly to obtain a needle body solution; 4) adding the needle tip solution prepared in step 2) to the negative mold microneedle array mold of 1) and filling the groove of the substrate with the solution, using a vacuum dryer to evacuate the air so that the needle tip solution enters the needle tip of the microneedle mold, then removing the residual solution on the surface, and drying in an oven or naturally; 5) adding the needle tip solution prepared in step 2) to the negative mold microneedle array mold of 4) and filling the groove of the substrate with the solution, using a vacuum dryer to evacuate the air so that the needle tip solution enters the needle tip of the microneedle mold, removing the residual solution on the surface, and drying in an oven or naturally to concentrate the needle tip; 6) Add the needle body solution prepared in step 3) to the negative mold microneedle array mold of 1), and fill the groove of the substrate with the solution, use a vacuum dryer to evacuate the air, so that the needle body solution fills the needle body part and the substrate of the microneedle mold, dry at room temperature, and obtain soluble microneedles loaded with tellurium nanoparticles after demolding.
9. The method for preparing soluble microneedles loaded with tellurium nanoparticles according to claim 7, characterized in that: The mass percentage of the water-soluble high molecular polymer in the needle tip solution described in step 2) and the needle body solution described in step 3) is 20% to 35%; the concentration of the tellurium nanoparticle solution in step 3) is 50 to 800 μg / mL.
10. The method for preparing soluble microneedles loaded with tellurium nanoparticles according to claim 7, characterized in that: 4) The amount of the needle tip solution used is 50 to 250 μL, and the drying condition is drying at 20 to 50° C. for 2 to 5 hours.
11. The method for preparing soluble microneedles loaded with tellurium nanoparticles according to claim 7, characterized in that: 6) The amount of needle body solution used is 50 to 250 μL, and the drying time is 12 to 24 hours.
